To assess therapeutic efficacy and safety of Oncoxin plus Surafenib in hepatocellular carcinoma~To see if there is reduction in serum alpha fetoprotein level in hepatocellular carcinoma patients after administration of Oncoxin plus Surafenib~To see if there is reduction tumor size and or number in hepatocellular carcinoma patients after administration of Oncoxin plus Surafenib~To see if there is improvement of quality of life in hepatocellular carcinoma patients after administration of Oncoxin plus Surafenib~To see if there is improved survival in hepatocellular carcinoma patients after administration of Oncoxin plus Surafenib
Oncoxin in combination with Surafenib is safe and results in improved survival in patients with hepatocellular carcinoma (HCC)